1. Chaouat A., Naeije R., Weitzenblum E. Pulmonary hypertension in COPD. Eur Respir. J. 2008; 32: 1371–1385.

2. Chaouat A., Bugnet A.S., Kadaoui N. et al. Severe pulmonary hypertension and chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2005; 172: 189–194.

3. Wagner P.D. The real cause of exercise limitation in COPD. J. Appl. Physiol. 2008; 105: 75–78.

4. Pinto*Plata V.M., Celli*Cruz R.A., Vassaux C. et al. Differences in cardiopulmonary exercise tests results by American Thoracic Society / European Respiratory Societyglobal initiative for chronic obstructive pulmonary disease stage categories and gender. Chest 2007; 132: 1204–1211.

5. Holverda S., Bogaard H.J., Groepenhoff H. et al. Cardiopulmonary exercise tests characteristics in patients with chronic obstructive pulmonary disease and associated pulmonary hypertension. Respiration 2008; 76: 160–167.

6. Kitabatake A., Inoue M., Asao M. et al. Noninvasive evaluation of pulmonary hypertension by a pulsed Doppler technique. Circulation 1983; 68: 302–309.

7. Arcasoy S.M., Christie J.D., Ferrari V.A. et al. Echocardiographic assessment of pulmonary hypertension in patients with advanced lung disease. Am. J. Respir. Crit. Care Med. 2003; 167: 735–740.

8. O'Donnell D., Webb K. Point-counterpoint: the major limitation to exercise performance in COPD is dynamic hyperinflation. J. Appl. Physiol. 2008; 105: 753–755.

9. Debigare′ R., Maltais F. Point-counterpoint: the major limitation to exercise performance in COPD is lower limb muscle dysfunction. J. Appl. Physiol. 2008; 105: 751–753.

10. Sun X.G., Hansen E.J., Oudiz R. et al. Exercise pathophysiology inpatients with primary pulmonary hypertension. Circulation 2001; 104: 429–435.

11. Holverda S., Rietema H., Westerhof N. et al. Stroke volume increases to exercise in COPD is limited by increased pulmonary artery pressure. Heart 2008; 95: 137–141.

12. Rietema H., Holverda S., Bogaard H.J. et al. Sildenafil treatment in COPD does not affect stroke volume or exercise capacity. Eur. Respir. J. 2008; 31: 759–764.

13. Vassaux C., Torre*Bouscoulet L., Zeineldine S. et al. Effect of hyperinflation on the oxygen pulse as a marker of cardiac performance in COPD. Eur. Respir. J. 2008; 32: 1275–1282.

14. Scharf S.M., Iqbal M., Keller C. et al. Hemodynamic characterization of patients with severe emphysema. Am. J. Respir. Crit. Care Med. 2002; 166: 314–322.

15. Doi M., Nakano K., Hiramoto T., Kohno N. Significance of pulmonary artery pressure in emphysema patients with mild to moderate hypoxemia. Respir. Med. 2003; 97 (8): 915–920.